ETFs Pour $317 Million into Johnson & Johnson in October 2026 Rally

Johnson & Johnson (JNJ) experienced significant ETF buying activity last Friday, with a net inflow of $317.4 million. The move came after a mixed week, including a small net sell-off on October 1 and moderate buying on the previous two days. Over the past five sessions, ETFs have been net buyers in four instances, with the largest single-day inflow occurring on September 28 at $307.6 million.

The top ETFs driving this activity included DFAC, which invested $332.7 million and increased its stake by 82.98%, IVV with $25.0 million, and XLV with $4.3 million. In total, 38 ETFs added shares while 20 reduced their holdings. Johnson & Johnson, a healthcare giant with a market cap of $609.5 billion, has seen strong financial performance, including a 7.5% revenue increase over the past year and a 24.18% year-to-date return.

Investors will be watching whether this ETF buying trend continues, as the current streak of positive activity stands at one day. The company's robust fundamentals, including a 2.0% dividend yield and a GF Score of 83, suggest continued interest from both institutional and individual investors.